Ted L. Underiner

机构：Worldwide Clinical Trials (United States)

发表论文 34 篇 · 总被引 951 次 · h-index 19

代表论文

• Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates (2010 · Anti-Cancer Agents in Medicinal Chemistry · 被引 132)
• Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells (2005 · Blood · 被引 106)
• Designing Chemical Libraries for Lead Discovery (1996 · SLAS DISCOVERY · 被引 55)
• Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity (2010 · ACS Medicinal Chemistry Letters · 被引 50)
• Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4 H -indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent (2011 · Journal of Medicinal Chemistry · 被引 42)
• First Synthesis of Cytotoxic 8,9-Secokaurene Diterpenoids. An Enantioselective Route to (−)- O -Methylshikoccin and (+)- O -Methylepoxyshikoccin (1997 · Journal of the American Chemical Society · 被引 33)